Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase

Francisella tularensis causes tularemia, a highly contagious disease of animals and humans, but the virulence features of F. tularensis are poorly defined. F. tularensis and the related mouse pathogen Francisella novicida synthesize unusual lipid A molecules lacking the 4′-monophosphate group typically found in the lipid A of Gram-negative bacteria. LpxF, a selective phosphatase located on the periplasmic surface of the inner membrane, removes the 4′-phosphate moiety in the late stages of F. novicida lipid A assembly. To evaluate the relevance of the 4′-phosphatase to pathogenesis, we constructed a deletion mutant of lpxF and compared its virulence with wild-type F. novicida. Intradermal injection of 106 wild-type but not 108 mutant F. novicida cells is lethal to mice. The rapid clearance of the lpxF mutant is associated with a stronger local cytokine response and a greater influx of neutrophils compared with wild-type. The F. novicida mutant was highly susceptible to the cationic antimicrobial peptide polymyxin. LpxF therefore represents a kind of virulence factor that confers a distinct lipid A phenotype, preventing Francisella from activating the host innate immune response and preventing the bactericidal actions of cationic peptides. Francisella lpxF mutants may be useful for immunization against tularemia.

[1]  F. Nano,et al.  Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production , 1996, Molecular microbiology.

[2]  C. Raetz,et al.  Two-dimensional NMR spectroscopy and structures of six lipid A species from Rhizobium etli CE3. Detection of an acyloxyacyl residue in each component and origin of the aminogluconate moiety. , 2000, The Journal of biological chemistry.

[3]  Xiaoyuan Wang,et al.  Periplasmic Cleavage and Modification of the 1-Phosphate Group of Helicobacter pylori Lipid A* , 2004, Journal of Biological Chemistry.

[4]  P. Oyston,et al.  Tularemia vaccine: past, present and future , 2005, Antonie van Leeuwenhoek.

[5]  M. Saraste,et al.  FEBS Lett , 2000 .

[6]  M. Meltzer,et al.  Live vaccine strain of Francisella tularensis: infection and immunity in mice , 1991, Infection and immunity.

[7]  C. Raetz,et al.  Accumulation of a Lipid A Precursor Lacking the 4′-Phosphate following Inactivation of the Escherichia coli lpxKGene* , 1998, The Journal of Biological Chemistry.

[8]  E. Vinogradov,et al.  Structural analysis of Francisella tularensis lipopolysaccharide. , 2002, European journal of biochemistry.

[9]  R. Carlson,et al.  Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine. , 1994, The Journal of biological chemistry.

[10]  C. Raetz,et al.  Biochemistry of endotoxins. , 1990, Annual review of biochemistry.

[11]  Suzanne R. Kalb,et al.  A Phosphoethanolamine Transferase Specific for the Outer 3-Deoxy-D-manno-octulosonic Acid Residue of Escherichia coli Lipopolysaccharide , 2005, Journal of Biological Chemistry.

[12]  C. Raetz,et al.  Biosynthesis and function of phospholipids in Escherichia coli. , 1990, The Journal of biological chemistry.

[13]  M. Jobling,et al.  Structural Basis for the Activation of Cholera Toxin by Human ARF6-GTP , 2005, Science.

[14]  Xiaoyuan Wang,et al.  Expression Cloning and Periplasmic Orientation of the Francisella novicida Lipid A 4′-Phosphatase LpxF* , 2006, Journal of Biological Chemistry.

[15]  J. Rudolph,et al.  A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin. , 2005, Biochemistry.

[16]  Hening Lin,et al.  How pathogenic bacteria evade mammalian sabotage in the battle for iron , 2006, Nature chemical biology.

[17]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[18]  Samuel I. Miller,et al.  LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.

[19]  Zhimin Zhou,et al.  High-resolution NMR Spectroscopy of Lipid A Molecules Containing 4-Amino-4-deoxy-l-arabinose and Phosphoethanolamine Substituents , 2000, The Journal of Biological Chemistry.

[20]  Tara L. Kieffer,et al.  Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. , 2003, Microbes and infection.

[21]  Xiaoyuan Wang,et al.  MsbA Transporter-dependent Lipid A 1-Dephosphorylation on the Periplasmic Surface of the Inner Membrane , 2004, Journal of Biological Chemistry.

[22]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[23]  T. Ogawa,et al.  Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide. , 1997, Journal of biochemistry.

[24]  B. Finlay,et al.  Bacterial pathogenesis: exploiting cellular adherence. , 2003, Current opinion in cell biology.

[25]  Xiaoyuan Wang,et al.  Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida. , 2006, Biochemistry.

[26]  Anders Sjöstedt,et al.  The complete genome sequence of Francisella tularensis, the causative agent of tularemia , 2005, Nature Genetics.

[27]  C. Raetz,et al.  An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. , 2001, The Journal of biological chemistry.

[28]  D. Court,et al.  An efficient recombination system for chromosome engineering in Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[30]  T. Ogawa Chemical structure of lipid A from porphyromonas (bacteroides) gingivalis lipopolysaccharide , 1993, FEBS letters.

[31]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[32]  S. Akira,et al.  Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response , 2006, Nature Immunology.

[33]  S Falkow,et al.  Copyright © 1997, American Society for Microbiology Common Themes in Microbial Pathogenicity Revisited , 2022 .

[34]  B. Gibson,et al.  Novel Modification of Lipid A of Francisella tularensis , 2004, Infection and Immunity.

[35]  A. Kamath,et al.  Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenes , 1996, Molecular microbiology.

[36]  C. Raetz,et al.  A Formyltransferase Required for Polymyxin Resistance in Escherichia coli and the Modification of Lipid A with 4-Amino-4-deoxy-l-arabinose , 2005, Journal of Biological Chemistry.

[37]  M. Perry,et al.  Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen. , 2003, Microbial pathogenesis.

[38]  R. F. Wang,et al.  Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. , 1991, Gene.

[39]  Suzanne R. Kalb,et al.  A Methylated Phosphate Group and Four Amide-linked Acyl Chains in Leptospira interrogans Lipid A , 2004, Journal of Biological Chemistry.

[40]  P. Proost,et al.  Synergy in cytokine and chemokine networks amplifies the inflammatory response. , 2005, Cytokine & growth factor reviews.

[41]  Pascale Cossart,et al.  Bacterial Invasion: The Paradigms of Enteroinvasive Pathogens , 2004, Science.

[42]  Zhimin Zhou,et al.  Multi‐dimensional NMR structural analyses of purified Lipid X and Lipid A (endotoxin) , 1999 .

[43]  H L Houtzager,et al.  Antonie van Leeuwenhoek. , 1983, European journal of obstetrics, gynecology, and reproductive biology.

[44]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[46]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[47]  A. Shaw,et al.  Triggering TLR signaling in vaccination. , 2006, Trends in immunology.

[48]  Suzanne R. Kalb,et al.  Expression Cloning and Biochemical Characterization of a Rhizobium leguminosarum Lipid A 1-Phosphatase* , 2003, Journal of Biological Chemistry.

[49]  D. Golenbock,et al.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.

[50]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.